ECC4703: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
4
Conditions studied
16
US states with sites
2
Countries
Phase breakdown
Phase 1 1
Phase 2 1
Conditions being studied
| Condition | Trials |
|---|---|
| NASH | 2 |
| Dyslipidaemia | 1 |
| Metabolic Dysfunction-associated Steatohepatitis | 1 |
| Non-alcoholic Fatty Liver Disease (NAFLD) | 1 |
Recruiting trials involving ECC4703
- A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Study of ECC4703 With Sulfasalazine and Pitavastatin
Common questions
How many recruiting trials involve ECC4703?
2 recruiting trials across 4 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.